New Products In Brief

Ev3's Pipeline: Firm completes modular PMA application for its Pipeline embolization device to treat uncoilable or failed aneurysms, announced May 18. Ev3 says it anticipates an FDA advisory panel review of the endovascular treatment "sometime later in the year" and U.S. approval in 2011. Ev3 acquired the self-expanding cylindrical mesh implant through its purchase of Chestnut Medical Technologies in 2009 (1"The Gray Sheet" June 8, 2009)